Skip to content
MS
PW-011 Lipid Metabolism Catabolic/anabolic (fuel export) unreviewed

Ketogenesis

Acetyl-CoA (from beta-oxidation) Acetoacetate, D-beta-hydroxybutyrate, acetone
Compartment
Liver mitochondrial matrix
Main tissue
Liver only
Rate-limiting
Mitochondrial HMG-CoA synthase (HMGCS2)
Steps
5

Reaction steps

In source order, 5 total

showing 1–5
  1. 1

    2 acetyl-CoA → acetoacetyl-CoA + CoA-SH

    Notes

    Mitochondrial thiolase (acetyl-CoA acetyltransferase) condenses two acetyl-CoA molecules. This reaction is reversible and is shared conceptually with the terminal thiolysis step of β-oxidation.

  2. 2

    Acetoacetyl-CoA + acetyl-CoA + H2O → 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) + CoA-SH

    Mitochondrial HMG-CoA synthase (HMGCS2) 2.3.3.10 ST-0083 Irreversible/directional rate-limiting CoA-SH H2O
    Notes

    Mitochondrial HMG-CoA synthase (HMGCS2) catalyzes this condensation. It is the rate-limiting and committed step of ketogenesis; it is distinct from cytosolic HMG-CoA synthase used in cholesterol synthesis.

  3. 3

    HMG-CoA → acetoacetate + acetyl-CoA

    HMG-CoA lyase (HMGCL) 4.1.3.4 ST-0084 Irreversible/directional
    Notes

    HMG-CoA lyase cleaves HMG-CoA to the first ketone body, acetoacetate, and acetyl-CoA. No nucleotide cofactor is required.

  4. 4

    Acetoacetate + NADH + H+ ⇌ D-β-hydroxybutyrate + NAD+

    Notes

    Mitochondrial D-β-hydroxybutyrate dehydrogenase interconverts the two principal ketone bodies. The mitochondrial NADH/NAD+ ratio determines their ratio: high NADH generated by β-oxidation favors D-β-hydroxybutyrate.

  5. 5

    Acetoacetate → acetone + CO2

    Non-enzymatic (spontaneous decarboxylation) ST-0086 Irreversible/directional
    Notes

    Acetoacetate undergoes slow, largely spontaneous nonenzymatic decarboxylation to acetone in humans; acetone is volatile and exhaled. This is not a productive ATP-generating step and is not a regulated enzymatic reaction.

Showing all 5 steps.

Regulation

What speeds each enzyme up and what slows it down

Mitochondrial HMG-CoA synthase (HMGCS2)

Accelerated by

High acetyl-CoA from β-oxidation; PPARα-mediated expression; fasting

Inhibited by

High insulin/carbohydrate availability; low fatty-acid delivery

Hormonal

Glucagon and low insulin induce expression indirectly through fasting transcriptional programs; insulin suppresses ketogenesis

CPT-1

Accelerated by

Low malonyl-CoA, fatty-acyl-CoA availability

Inhibited by

Malonyl-CoA

Hormonal

Glucagon/epinephrine lower malonyl-CoA and increase fatty-acid entry; insulin opposes this

Hormone-sensitive lipase/ATGL in adipose (upstream fuel supply)

Accelerated by

Catecholamines, glucagon in humans, natriuretic peptides

Inhibited by

Insulin; phosphodiesterase-mediated cAMP degradation

Hormonal

Low insulin and counterregulatory hormones increase nonesterified-fatty-acid delivery to liver

D-β-hydroxybutyrate dehydrogenase

Accelerated by

High mitochondrial NADH/NAD+ ratio

Inhibited by

Lower NADH/NAD+ ratio

Hormonal

Regulated primarily by redox state, not direct phosphorylation

Overview

Ketogenesis converts excess hepatic mitochondrial acetyl-CoA into the water-soluble ketone bodies acetoacetate and D-β-hydroxybutyrate; acetone is a minor spontaneous breakdown product. It is activated in prolonged fasting, starvation, sustained exercise, uncontrolled type 1 diabetes mellitus, and other states with high glucagon-to-insulin signaling. Ketone bodies export energy from liver to extrahepatic tissues while sparing glucose and, during prolonged fasting, reducing the need for proteolysis to supply gluconeogenic amino acids.

Cellular location

Ketogenesis occurs exclusively in the mitochondrial matrix of hepatocytes, chiefly periportal liver cells. The liver synthesizes but cannot consume ketone bodies because it lacks succinyl-CoA:3-ketoacid CoA transferase (SCOT/OXCT1). Ketone bodies cross membranes and circulate freely without lipoprotein carriers or albumin.

Net energetics

Ketogenesis itself does not produce ATP; it repackages acetyl-CoA into exportable fuel. Net formation of acetoacetate uses 2 acetyl-CoA and releases two CoA-SH; formation of D-β-hydroxybutyrate additionally consumes 1 NADH + H+ per acetoacetate reduced. The energy is recovered in extrahepatic tissues during ketolysis and subsequent oxidation of acetyl-CoA.

Clinical significance

Physiological ketosis supports brain, skeletal muscle, and heart during carbohydrate scarcity, while erythrocytes cannot use ketones because they lack mitochondria. In insulin-deficient diabetes, unchecked lipolysis and ketogenesis can produce high-anion-gap metabolic acidosis—diabetic ketoacidosis (DKA)—with dehydration, Kussmaul respirations, and fruity acetone breath. HMG-CoA lyase deficiency impairs ketone production and may cause hypoketotic hypoglycemia during fasting or illness. Nutritional ketosis is regulated and generally much less acidemic than DKA because insulin is present.

Recent literature

Live Europe PMC search

Europe PMC · from cache · sorted by publication date

  1. 1
    SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism.

    Habas E, Rayani A, Habas A, Alarbi K, Habas A, Baghi M, Habas E, Errayes E, Hamad A, Elzouki A. · 2026-07-02

    unreviewed
  2. 2
    Sulfide dynamics at the gut-microbiota interface: diet, oxygen and redox interplay.

    Kumar R, Banerjee R. · 2026-06-02

    open access unreviewed
  3. 3
    Gut microbiota reshapes host energy metabolism to modulate depressive behaviors.

    Lei P, Qi Z, Ma Q, Zhao B, Wen B, Jiang W, Xi W, Liu Y, Xun Y, Zhang S, Wang Y, Guo Y, Wang W, Ma X, Jia M, F… · 2026-04-23

    open access unreviewed
  4. 4
    Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study.

    Gao M, Lin Q, Hu K, Zhong B, Zhu T, Gong Z, Zhang K, Chen X, Chen X, Zhang Y, Li Y, Tang S, Su D, Liang X, Li… · 2026-02-02

    open access unreviewed
  5. 5
    Maternal obesity alters human milk oligosaccharides content and correlates with early acquisition of late colonizers in the neonatal gut microbiome.

    Corona-Cervantes K, Urrutia-Baca VH, Gámez-Valdez JS, Jiménez-López B, Rodríguez-Gutierrez NA, Chávez-Caraza … · 2026-01-15

    cited 2× open access unreviewed
  6. 6
    cAMP-PKA/EPAC signaling pathways: crucial regulators of lipid homeostasis.

    Chen C, Gao H, Tian Q, Cao J. · 2026-01-07

    open access unreviewed
  7. 7
    The ketogenic diet is not for everyone: contraindications, side effects, and drug interactions.

    Dyńka D, Rodzeń Ł, Rodzeń M, Łojko D, Karakuła-Juchnowicz H, Ede G, Grzywacz Ż, Antosik K, Sethi S, Unwin D. · 2026-01-04

    cited 4× open access unreviewed
  8. 8
  9. 9
    Lipoprotein metabolism and inflammation in healthy young subjects - exploring the postprandial and postabsorptive phases following intake of a standardized meal.

    Jensen SM, Holven KB, Ulven SM, Anfinsen ÅM, Dierkes J, Lysne V, Christensen JJ. · 2026-06-03

    open access unreviewed
  10. 10
    SGLT2 Inhibitors in Type 1 Diabetes: The Metabolic Perspective.

    Hamidi V, Mudaliar S. · 2026-08-13

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.